Key result
Blocking iNOS-derived nitric oxide cuts basal K+ channel activity ~63% in human proximal tubule cells.
Why the study?
The specific NOS isoform(s) involved in endogenous NO production regulating inwardly rectifying K+ channel activity in human proximal tubule cells was unclear.
Absolute Event Rate: 36.8% vs 100%
p-value: p=<0.01
In cultured human proximal tubule cells, iNOS plays a pivotal role in the endogenous production of nitric oxide that regulates inwardly rectifying K+ channel activity.
Does not alter clinical practice; leaves open specific NOS isoform roles in renal K+ channel regulation.
Nitric oxide (NO) modulates the activity of an inwardly rectifying K(+) channel in cultured human proximal tubule cells. In this study, we investigated which NO synthase (NOS) isoform(s) was involved in the endogenous production of NO and hence the regulation of channel activity. The patch-clamp experiments using the cell-attached mode showed that a nonselective NOS inhibitor, N(omega)-nitro-L-arginine methyl ester (L-NAME; 100 microM), suppressed channel activity, whereas a NOS substrate, L-arginine (500 microM), stimulated it. A neuronal NOS (nNOS)/inducible NOS (iNOS)-selective inhibitor, 1-(alpha,alpha,alpha-trifluoro-o-tolyl)-imidazole (TRIM; 100 microM), suppressed channel activity to the same extent as L-NAME. TRIM also blocked the stimulatory effect of L-arginine. In contrast, an NO donor, sodium nitroprusside (10 microM) or 8-bromoguanosine 3',5'-cyclic monophosphate (100 microM) stimulated channel activity even in the presence of TRIM. RT-PCR revealed that iNOS mRNA alone was expressed in most of the cultures, i.e., 34 out of 40. In the other 6 cases, endothelial NOS (eNOS) and iNOS mRNA were simultaneously expressed. This finding was confirmed at the protein level by Western blotting. Indeed, in the patch-clamp experiments TRIM sometimes failed to suppress the channel activity, but the following addition of L-NAME suppressed it. However, since the suppressive effect of TRIM was usually similar to that of L-NAME, the involvement of eNOS in K(+) channel regulation would be relatively low. These results suggest that iNOS plays a pivotal role in the endogenous production of NO under the basal condition, which is involved in the activity of the inwardly rectifying K(+) channel in cultured human proximal tubule cells.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2006) studied Normal renal proximal tubule epithelial cells (in vitro). NOS inhibitors (L-NAME, TRIM) and NOS substrate (L-arginine) vs. Baseline channel activity (control) was evaluated on Normalized K+ channel activity (NPo,e/NPo,c) after L-NAME administration (p=<0.01). In cultured human proximal tubule cells, endogenous nitric oxide produced primarily by inducible nitric oxide synthase (iNOS) maintains the basal activity of inwardly rectifying K+ channels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: